Conversion to aflibercept for diabetic macular edema unresponsive to ranibizumab or bevacizumab

BACKGROUND: The purpose of this study was to determine if eyes with diabetic macular edema (DME) unresponsive to ranibizumab or bevacizumab would benefit from conversion to aflibercept. METHODS: This study was conducted as a retrospective chart review of subjects with DME unresponsive to ranibizumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Laurence S, Ng, Wei Yan, Mathur, Ranjana, Wong, Doric, Wong, Edmund YM, Yeo, Ian, Cheung, Chui Ming Gemmy, Lee, Shu Yen, Wong, Tien Yin, Papakostas, Thanos D, Kim, Leo A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577250/
https://www.ncbi.nlm.nih.gov/pubmed/26396494
http://dx.doi.org/10.2147/OPTH.S81523

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577250/
https://www.ncbi.nlm.nih.gov/pubmed/26396494
http://dx.doi.org/10.2147/OPTH.S81523

Ejemplares similares